Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00606840 · ClinicalTrials.gov registry record · NA

Weight Gain Prevention

A NA study of Weight Gain, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT00606840: Completed NA study of Weight Gain, sponsored by The Miriam Hospital.

NCT00606840 is a NA study of Weight Gain that has completed, run by The Miriam Hospital. The registered enrollment target is 52 participants, below the 220-participant average among 38 other Weight Gain trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00606840, a NA study of Weight Gain, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

The specific aim of the proposed project is to test two separate self-regulation interventions to prevent weight gain in young adults, one based on making sustained small changes in behavior to prevent weight gain and the other on making periodic larger behavior changes resulting in weight loss.

Conditions Studied

Interventions

  • BEHAVIORAL large changes in eating and activity
  • BEHAVIORAL small changes in eating and activity

Study Locations (1)

Rhode Island

  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2008-01
Est. Completion 2008-09
Phase NA
The Miriam Hospital

136 total trials

What the finished NCT00606840 record still lists

NCT00606840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 220-participant average among 38 other Weight Gain trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Weight Gain appearing as the primary indexed condition, and to 2 interventions - of which large changes in eating and activity is the first listed.

NCT00606840 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT00606840 about?

NCT00606840 is a clinical study titled "Weight Gain Prevention". The specific aim of the proposed project is to test two separate self-regulation interventions to prevent weight gain in young adults, one based on making sustained small changes in behavior to prevent weight gain and the other on making periodic larger behavior changes resulting in weight loss.

What is the current status of trial NCT00606840?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2008-01. Estimated completion is 2008-09.

What conditions does trial NCT00606840 study?

This clinical trial studies the following conditions: Weight Gain.

What interventions are being tested in trial NCT00606840?

The interventions under investigation include: large changes in eating and activity (BEHAVIORAL), small changes in eating and activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT00606840?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00606840 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Gain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00606840's enrollment target sits among peer trials

52 23rd of 38 higher than 16 of 38 other Weight Gain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Weight Gain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02630121 · 52 participants · Phase 4

    Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

  • NCT03629171 · 52 participants · Phase 2

    Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

  • NCT04128748 · 52 participants · Phase 1

    Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

  • NCT04150497 · 52 participants · Phase 1

    Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00606840, the US trial registry maintained by the National Library of Medicine. NCT00606840 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.